GL1X · GenesisL1 explorer

Research workbench

HIV-1 reverse transcriptase in complex with inhibitor GSK500

Analyse HIV-1 reverse transcriptase in complex with inhibitor GSK500 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2YNH
Type
protein
Length
966 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Reverse TRANSCRIPTASE/RIBONUCLEASE H; P51 rt
EC
2.7.7.49, 2.7.7.7, 3.1.26.13, 3.1.13.2
UniProt
P04585
Ligands
EUR
Pockets
18 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 34% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AReverse TRANSCRIPTASE/RIBONUCLEASE H (EC 2.7.7.49, 2.7.7.7, 3.1.26.13, 3.1.13.2)protein56032% helix, 23% strandP04585
BP51 rtprotein40636% helix, 19% strandP04585

Ligands and binding sites

  • EUR · 4-chloranyl-N-[[4-chloranyl-3-(3-chloranyl-5-cyano-phenoxy)-2-fluoranyl-phenyl]methyl]-2-(hydroxymethyl)-1H-imidazole-5-carboxamide · ligand · chains A
  • TAR · D(-)-tartaric acid · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

18 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17040.770.8273EUR
22870.680.8341empty
33480.650.8032empty
43260.620.7846empty
52210.610.8131empty

Interfaces

1 interface between chains.

  • A–B · 2941 Ų buried · 31 hydrogen bonds · protein-protein

Compared structures

  • 2YNH · HIV-1 Reverse Transcriptase in complex with inhibitor GSK500 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.